Holen Sie sich die Stockscreener-App
152.37
1.20%
1.81
Schlusskurs vom Vortag:
$150.56
Offen:
$144.81
24-Stunden-Volumen:
1.59M
Relative Volume:
1.72
Marktkapitalisierung:
$8.57B
Einnahmen:
$633.51M
Nettoeinkommen (Verlust:
$-8.10M
KGV:
-491.52
EPS:
-0.31
Netto-Cashflow:
$131.26M
1W Leistung:
+6.69%
1M Leistung:
+2.68%
6M Leistung:
+19.00%
1J Leistung:
+6.98%
1-Tages-Spanne:
$144.81
$154.79
1-Wochen-Bereich:
$144.40
$158.74
52-Wochen-Spanne:
$102.97
$182.52
Repligen Corp Stock (RGEN) Company Profile
Firmenname
Repligen Corp
Sektor
Telefon
(781) 449-9560
Adresse
41 SEYON STREET, WALTHAM, MA
Vergleichen Sie RGEN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RGEN
Repligen Corp
|
152.37 | 8.48B | 633.51M | -8.10M | 131.26M | -0.31 |
|
ISRG
Intuitive Surgical Inc
|
549.51 | 200.47B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
193.04 | 55.33B | 21.84B | 1.68B | 2.67B | 5.8322 |
|
ALC
Alcon Inc
|
77.65 | 38.61B | 10.19B | 1.05B | 1.39B | 2.1065 |
|
RMD
Resmed Inc
|
244.46 | 36.80B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
WST
West Pharmaceutical Services Inc
|
261.36 | 19.18B | 2.96B | 487.70M | 344.00M | 6.6758 |
Repligen Corp Stock (RGEN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-01 | Eingeleitet | HSBC Securities | Buy |
| 2025-09-22 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-22 | Fortgesetzt | Stephens | Overweight |
| 2025-06-24 | Eingeleitet | Barclays | Overweight |
| 2025-04-29 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-03-18 | Eingeleitet | Evercore ISI | In-line |
| 2025-02-10 | Eingeleitet | TD Cowen | Buy |
| 2024-12-17 | Eingeleitet | Canaccord Genuity | Hold |
| 2024-11-14 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-06-18 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-04 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-07-20 | Eingeleitet | Wells Fargo | Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-03-28 | Eingeleitet | The Benchmark Company | Buy |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2022-07-20 | Eingeleitet | UBS | Buy |
| 2021-10-14 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-08-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-05-07 | Bestätigt | H.C. Wainwright | Buy |
| 2020-03-23 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-11-01 | Hochstufung | First Analysis Sec | Outperform → Strong Buy |
| 2019-10-15 | Eingeleitet | SVB Leerink | Outperform |
| 2019-08-28 | Bestätigt | First Analysis Sec | Outperform |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2019-07-22 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2018-12-17 | Hochstufung | CL King | Neutral → Buy |
| 2018-11-12 | Herabstufung | CL King | Buy → Neutral |
| 2018-09-26 | Eingeleitet | H.C. Wainwright | Neutral |
| 2017-12-08 | Eingeleitet | Citigroup | Buy |
| 2017-12-05 | Eingeleitet | JP Morgan | Overweight |
| 2017-11-13 | Eingeleitet | CL King | Buy |
| 2017-10-02 | Hochstufung | First Analysis Sec | Equal-Weight → Overweight |
| 2017-07-21 | Eingeleitet | William Blair | Outperform |
| 2017-02-13 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Repligen Corp Aktie (RGEN) Neueste Nachrichten
Is Repligen Corporation a good long term investmentPortfolio Allocation Tips & Market Volatility Strategies - earlytimes.in
Will Repligen Corporation (RGN) stock benefit from mergersLong Setup & Weekly Top Performers Watchlists - newser.com
There is no doubt that Repligen Corp (RGEN) ticks all the boxes. - setenews.com
How to forecast Repligen Corporation trends using time seriesTrade Exit Summary & High Return Trade Opportunity Guides - newser.com
Using Python tools to backtest Repligen Corporation strategiesMarket Growth Report & Comprehensive Market Scan Reports - newser.com
Real time breakdown of Repligen Corporation stock performance - newser.com
How Repligen Corporation stock performs during Fed tightening cyclesJuly 2025 Sentiment & Stock Portfolio Risk Management - newser.com
Repligen stock rating reiterated at Buy by Stifel on strong business outlook - Investing.com
Lantheus, Enovis, Evolent Health, Repligen, and Corcept Shares Are Soaring, What You Need To Know - Yahoo Finance
Repligen at Stifel Conference: Strong Growth Amid Challenges - Investing.com
Repligen at UBS Global Healthcare: Strategic Growth and Market Positioning - Investing.com
How Repligen Corporation stock trades before earningsEarnings Overview Report & Expert Approved Momentum Ideas - newser.com
Relative strength of Repligen Corporation in sector analysisPortfolio Return Report & Real-Time Market Sentiment Alerts - newser.com
Repligen Bets Big On Bioprocessing Innovation—But At A Price - Finimize
RGEN (Repligen) Scaled Net Operating Assets : 0.70 (As of Sep. 2025) - GuruFocus
Custom strategy builders for tracking Repligen CorporationMarket Activity Report & Growth Oriented Trade Recommendations - newser.com
Repligen (RGEN) to Release Earnings on Tuesday - Defense World
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN) - Yahoo Finance
Repligen Corporation (RGEN) Stock forecasts - Yahoo Finance UK
RGEN (Repligen) Other Gross PPE : $419.2 Mil (As of Sep. 2025) - GuruFocus
AlphaQuest LLC Makes New Investment in Repligen Corporation $RGEN - Defense World
Repligen Corporation (RGEN) Stock Forecasts - Yahoo! Finance Canada
RGEN (Repligen) YoY EBITDA Growth : 82.82% (As of Sep. 2025) - GuruFocus
Why retail investors pile into Repligen Corporation stockPortfolio Risk Report & Reliable Intraday Trade Alerts - Fundação Cultural do Pará
RGEN (Repligen) Cash And Cash Equivalents : $708.9 Mil (As of Jun. 2025) - GuruFocus
Repligen (RGEN): Assessing Valuation After Q3 Profits and Raised 2025 Guidance - Yahoo Finance
Does Repligen Corporation stock trade at a discount to peersJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Smart tools for monitoring Repligen Corporation’s price actionSwing Trade & Trade Opportunity Analysis - newser.com
RGEN (Repligen) EPS without NRI : $1.66 (TTM As of Jun. 2025) - GuruFocus
[10-Q] REPLIGEN CORP Quarterly Earnings Report | RGEN SEC FilingForm 10-Q - Stock Titan
Repligen (NASDAQ: RGEN) to join five investor conferences in November; webcast access - Stock Titan
Repligen Corporation to Present at Upcoming November Conferences - Yahoo Finance
Repligen (NASDAQ:RGEN) Cut to Hold at Wall Street Zen - MarketBeat
Repligen Corporation (RGEN) Stock Price, News, Quote & History - Yahoo! Finance Canada
Should you hold or exit Repligen Corporation nowJuly 2025 Analyst Calls & Scalable Portfolio Growth Ideas - newser.com
Versor Investments LP Sells 2,212 Shares of Repligen Corporation $RGEN - MarketBeat
5 Revealing Analyst Questions From Repligen’s Q3 Earnings Call - Yahoo Finance
Can volume confirm reversal in Repligen Corporation2025 Dividend Review & Short-Term High Return Ideas - newser.com
What technical patterns form on Repligen Corporation (RGN) stock chartsStock Surge & Stock Portfolio Risk Control - newser.com
Pier Capital LLC Sells 4,692 Shares of Repligen Corporation $RGEN - MarketBeat
Geneva Capital Management LLC Purchases 343,991 Shares of Repligen Corporation $RGEN - MarketBeat
Repligen Corp (RGEN) Stock Price, Trades & News - GuruFocus
RGEN (Repligen) EBIT : $26.1 Mil (TTM As of Jun. 2025) - GuruFocus
Research Analysts Offer Predictions for Repligen Q1 Earnings - Defense World
William Blair Has Negative View of Repligen FY2025 Earnings - MarketBeat
Finanzdaten der Repligen Corp-Aktie (RGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.23%
0.58%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):